Role of Low Dose Injectable Progesterone in Triggering Ovulation

Launched by THE GENERAL AUTHORITY FOR TEACHING HOSPITALS AND INSTITUTES · Apr 7, 2025

Keywords

ClinConnect Summary

This clinical trial is investigating how low doses of injectable progesterone can help trigger ovulation in women who are having difficulty getting pregnant. The researchers want to see if this treatment can be effective for women aged 20 to 35 who are considered infertile, meaning they have not been able to conceive after trying for a while. To qualify for the study, participants need to have certain hormone levels and cannot have other health issues that might interfere with the treatment, such as certain medical conditions or weight concerns.

If you choose to participate, you will receive the injectable progesterone and be monitored closely to see how your body responds. The trial is currently recruiting participants, so if you or someone you know meets the eligibility criteria and is interested in exploring this potential treatment, it might be a good opportunity to consider. Your involvement could help contribute to important research that could benefit many women facing similar challenges.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age from 20 to 35 years.
• • Infertile women.
• • Basal follicle-stimulating hormone (FSH) level \<10 mIU/ml.
• Exclusion Criteria:
• • Poor ovarian reserve.
• • Immunological disease.
• • Endometriosis.
• • Uterine abnormality.
• • Body mass index (BMI) \>30 kg/m2.
• • Endometrial thickness \<8 or \>12 mm on the day of triggering.